ACADIA Pharmaceuticals, Inc. (ACAD)

24.75 +0.76 (+3.17%) USD  |  NASDAQ  |  Feb 23, 16:00
24.75 0.00 (0.00%) After-Hours: 17:16
More

ACADIA Pharmaceuticals EBITDA (% of Quarterly Revenues)

EBITDA (% of Quarterly Revenues) Chart

View EBITDA (% of Quarterly Revenues) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (% of Quarterly Revenues) Range, Past 5 Years

View EBITDA (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (% of Quarterly Revenues) Benchmarks

View EBITDA (% of Quarterly Revenues) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
Dynavax Technologies Corp. (DELISTED) Upgrade
Axsome Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade